AUROPHARMADisclaimer:
This is not financial advice. Please do your own research or consult with a financial advisor before making any investment decisions. Investments in stocks can be risky and may result in loss of capital.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
61.25 INR
31.73 B INR
287.25 B INR
274.12 M
About AUROBINDO PHARMA LTD
Sector
CEO
Kambam Nithyananda Reddy
Headquarters
Hyderabad
Website
Founded
1986
ISIN
INE406A01037
FIGI
BBG000BMFTS8
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Stock Analysis Report: Aurobindo Pharma Ltd.Overview:
The chart presents a technical analysis of Aurobindo Pharma Ltd. on a daily timeframe. The stock shows a recovery pattern with a visible RSI divergence, indicating a potential bullish reversal.
Key Observations:
1.RSI Divergence:
A bullish divergence is identified as the price ma
AUROPHARMAPerfect bounce from OB at 1185-1205
Also support in golden fib zone (985-1580)
Entry - 1225 - 1230
SL - 1170 - 1175
T1: 1400
T2: 1550
DISCLAIMER: Not financial advice. Only for educational purposes.
Invest at your own risk
Aurobindo Pharma Long TradeHello,
Trend-Based Analysis. Buy the Dips, Sell The Rallies, Also Following the Trend. Let's see where the Price Action takes us, Riding the wave. Potential trade setups based on trend momentum.
Technical analysis based on trend identification and momentum, Looking for high-probability setups with
Aurobindo Pharma reversal likelyThe stock has corrected significantly. It is now at weekly long term support . hammer formation seen on daily TF . In addition there is RSI bullish divergence. short term up move is highly likely
AUROPHARMA NSE:AUROPHARMA
Good Sock of Mid Cap Sector
Taken Support 1215
Long Term Target is 1550++
SL- 1181
Closed on 10 Day MA
auropharma short term CE oppngo long
sl of 1219
on daily it has come to 2.0 of FIB o its downside.
go easy, not an aggressive opportunity.
Aurobindo Pharma Ltd view for Intraday 13th Nov #AUROPHARMA Aurobindo Pharma Ltd view for Intraday 13th Nov #AUROPHARMA
Resistance 1280 Watching above 1282 for upside movement...
Support area 1250. Below 1265 ignoring upside momentum for intraday
Support 1250.Watching below 1248 for downside movement...
Resistance area 1280
Above 1265 ignoring downside mo
AUROPHARMA NSE BULLISH FLAG /RBC&H 7M AUROPHARMA WTF Analysis
TRADE PLAN
ENTRY -1510 -1550 On BO of Bullish Fage DTF Close
SL -1405 or Weekly Low Close Price
TARGET --01-1719 , TGT02--1931
Hold For a Year or TGT 2
Chart Pattern :
STOCK has recently touched its LTH of 1592. Previously Impulse after forming a 2Y-7M RBC on the DTF/W
AUROPHARAM Swing Long SetupEnter only when 15minute candle closes above the Entry Zone Price - 1461.70
Target with Risk to reward 1:2 is 1571.1
Stoploss only when 1 day candle closes below the price - 1407
Note: This is not any financial advice, this is for education purpose only.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AUROPHARMA is 1,241.70 INR — it has decreased by −1.04% in the past 24 hours. Watch AUROBINDO PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AUROBINDO PHARMA LTD stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has risen by 2.11% compared to the previous week, the month change is a 0.21% rise, over the last year AUROBINDO PHARMA LTD has showed a 20.20% increase.
We've gathered analysts' opinions on AUROBINDO PHARMA LTD future price: according to them, AUROPHARMA price has a max estimate of 1,930.00 INR and a min estimate of 1,225.00 INR. Watch AUROPHARMA chart and read a more detailed AUROBINDO PHARMA LTD stock forecast: see what analysts think of AUROBINDO PHARMA LTD and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Sep 13, 2024 with the price of 1,592.00 INR, and its all-time low was 4.60 INR and was reached on Jan 4, 1999. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 3.20% volatile and has beta coefficient of 0.88. Track AUROBINDO PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is AUROBINDO PHARMA LTD there?
Today AUROBINDO PHARMA LTD has the market capitalization of 720.60 B, it has decreased by −1.00% over the last week.
Yes, you can track AUROBINDO PHARMA LTD financials in yearly and quarterly reports right on TradingView.
AUROBINDO PHARMA LTD is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 14.00 INR per share, whereas the estimation was 16.05 INR resulting in a −12.75% surprise. The estimated earnings for the next quarter are 15.42 INR per share. See more details about AUROBINDO PHARMA LTD earnings.
AUROBINDO PHARMA LTD revenue for the last quarter amounts to 77.96 B INR, despite the estimated figure of 77.88 B INR. In the next quarter, revenue is expected to reach 76.70 B INR.
AUROPHARMA net income for the last quarter is 8.17 B INR, while the quarter before that showed 9.19 B INR of net income which accounts for −11.08% change. Track more AUROBINDO PHARMA LTD financial stats to get the full picture.
As of Dec 21, 2024, the company has 37.60 K employees. See our rating of the largest employees — is AUROBINDO PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA LTD EBITDA is 64.74 B INR, and current EBITDA margin is 19.89%. See more stats in AUROBINDO PHARMA LTD financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA LTD stock shows the buy signal. See more of AUROBINDO PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.